Abstract | BACKGROUND:
Liver cirrhosis is a potentially life-threatening disease caused by progressive displacement of functional hepatocytes by fibrous tissue. The underlying fibrosis is often driven by chronic infection with hepatitis B virus (HBV). Matrix metalloproteinases including MMP-8 are crucial for excess collagen degradation. In a rat model of liver cirrhosis, MMP-8 delivery by an adenovirus (Ad) vector achieved significant amelioration of fibrosis but application of Ad vectors in humans is subject to various issues, including a lack of intrinsic liver specificity. METHODS: HBV is highly liver-specific and its principal suitability as liver-specific gene transfer vector is established. HBV vectors have a limited insertion capacity and are replication-defective. Conversely, in an HBV infected cell vector replication may be rescued in trans by the resident virus, allowing conditional vector amplification and spreading. Capitalizing on a resident pathogen to help in its elimination and/or in treating its pathogenic consequences would provide a novel strategy. However, resident HBV may also reduce susceptibility to HBV vector superinfection. Thus a size-compatible truncated MMP-8 (tMMP8) gene was cloned into an HBV vector which was then used to generate a chimeric Ad-HBV shuttle vector that is not subject to superinfection exclusion. Rats with thioacetamide-induced liver cirrhosis were injected with the chimera to evaluate therapeutic efficacy. RESULTS: Our data demonstrate that infectious HBV vector particles can be obtained via trans-complementation by wild-type virus, and that the tMMP8 HBV vector can efficiently be shuttled by an Ad vector into cirrhotic rat livers. There it exerted a comparable beneficial effect on fibrosis and hepatocyte proliferation markers as a conventional full-length MMP-8Ad vector. CONCLUSIONS: Though the rat cirrhosis model does not allow assessing in vivo HBV vector amplification these results advocate the further development of Ad-HBV vectors for liver-specific gene therapy, including and perhaps particularly for HBV-related disease.
|
Authors | Jinxia Liu, Xin Cheng, Zhengrong Guo, Zihua Wang, Dong Li, Fubiao Kang, Haijun Li, Baosheng Li, Zhichen Cao, Michael Nassal, Dianxing Sun |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 1
Pg. e53392
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 23301066
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Collagen
- MMP8 protein, human
- Matrix Metalloproteinase 8
|
Topics |
- Adenoviridae
(genetics)
- Animals
- Cell Proliferation
- Collagen
(metabolism)
- Disease Models, Animal
- Fibrosis
- Genetic Therapy
(methods)
- Genetic Vectors
(genetics)
- Hep G2 Cells
- Hepatitis B virus
(genetics)
- Hepatocytes
(cytology)
- Humans
- Liver
(metabolism)
- Liver Cirrhosis
(metabolism, therapy)
- Matrix Metalloproteinase 8
(metabolism, therapeutic use)
- Microscopy, Fluorescence
- Rats
- Transfection
|